These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19683345)

  • 1. Comparison of the ability of wild type and stabilized human IgG(4) to undergo Fab arm exchange with endogenous IgG(4)in vitro and in vivo.
    Lewis KB; Meengs B; Bondensgaard K; Chin L; Hughes SD; Kjaer B; Lund S; Wang L
    Mol Immunol; 2009 Oct; 46(16):3488-94. PubMed ID: 19683345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
    Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
    J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys.
    Stubenrauch K; Wessels U; Regula JT; Kettenberger H; Schleypen J; Kohnert U
    Drug Metab Dispos; 2010 Jan; 38(1):84-91. PubMed ID: 19850673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S228P mutation prevents in vivo and in vitro IgG4 Fab-arm exchange as demonstrated using a combination of novel quantitative immunoassays and physiological matrix preparation.
    Silva JP; Vetterlein O; Jose J; Peters S; Kirby H
    J Biol Chem; 2015 Feb; 290(9):5462-9. PubMed ID: 25568323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength.
    Labrijn AF; Rispens T; Meesters J; Rose RJ; den Bleker TH; Loverix S; van den Bremer ET; Neijssen J; Vink T; Lasters I; Aalberse RC; Heck AJ; van de Winkel JG; Schuurman J; Parren PW
    J Immunol; 2011 Sep; 187(6):3238-46. PubMed ID: 21841137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys.
    Whipple EC; Ditto AH; Shanahan RS; Gatesman JJ; Little SF; Taylor RP; Lindorfer MA
    Mol Immunol; 2007 Jan; 44(4):377-88. PubMed ID: 16631928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of a mouse Fab into a whole humanized IgG antibody for detecting botulinum toxin.
    Palys TJ; Schmid KE; Scherer JM; Schoepp RJ
    Hum Antibodies; 2006; 15(4):125-32. PubMed ID: 17522434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility of human IgG subclasses.
    Roux KH; Strelets L; Michaelsen TE
    J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region.
    Handlogten MW; Peng L; Christian EA; Xu W; Lin S; Venkat R; Dall'Acqua W; Ahuja S
    MAbs; 2020; 12(1):1779974. PubMed ID: 32633193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid IgG4/IgG4 Fc antibodies form upon 'Fab-arm' exchange as demonstrated by SDS-PAGE or size-exclusion chromatography.
    Rispens T; den Bleker TH; Aalberse RC
    Mol Immunol; 2010 Apr; 47(7-8):1592-4. PubMed ID: 20299101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of immunoglobulin G4 Fab-arm exchange.
    Rispens T; Ooijevaar-de Heer P; Bende O; Aalberse RC
    J Am Chem Soc; 2011 Jul; 133(26):10302-11. PubMed ID: 21627172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange.
    Hansen K; Ruttekolk IR; Glauner H; Becker F; Brock R; Hannus S
    Mol Immunol; 2009 Oct; 46(16):3269-77. PubMed ID: 19699529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells.
    Nagy ZA; Hubner B; Löhning C; Rauchenberger R; Reiffert S; Thomassen-Wolf E; Zahn S; Leyer S; Schier EM; Zahradnik A; Brunner C; Lobenwein K; Rattel B; Stanglmaier M; Hallek M; Wing M; Anderson S; Dunn M; Kretzschmar T; Tesar M
    Nat Med; 2002 Aug; 8(8):801-7. PubMed ID: 12101408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of self-association of a human monoclonal antibody CNTO607.
    Bethea D; Wu SJ; Luo J; Hyun L; Lacy ER; Teplyakov A; Jacobs SA; O'Neil KT; Gilliland GL; Feng Y
    Protein Eng Des Sel; 2012 Oct; 25(10):531-7. PubMed ID: 22915597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum levels of natalizumab, an immunoglobulin G4 therapeutic monoclonal antibody.
    Rispens T; Leeuwen Av; Vennegoor A; Killestein J; Aalberse RC; Wolbink GJ; Aarden LA
    Anal Biochem; 2011 Apr; 411(2):271-6. PubMed ID: 21216215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
    Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange.
    van der Neut Kolfschoten M; Schuurman J; Losen M; Bleeker WK; Martínez-Martínez P; Vermeulen E; den Bleker TH; Wiegman L; Vink T; Aarden LA; De Baets MH; van de Winkel JG; Aalberse RC; Parren PW
    Science; 2007 Sep; 317(5844):1554-7. PubMed ID: 17872445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Rabbit Monoclonal Antibodies for Quantitation of Therapeutic Human Antibodies in Preclinical Non-Human Primate Studies.
    Chu R; Gerstein J; Wu H; Huang H; Lou Y; Palmer R
    Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):175-183. PubMed ID: 32996830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.